The first randomized controlled trial of its kind aimed at identifying an effective way to manage myopia was published last week. A study conducted at Vanderbilt University Medical Center and 11 other ...

A study conducted at Vanderbilt University Medical Center and 11 other hospitals and practices across the United States shows that use of low-dose atropine eyedrops, commonly used in a higher dose to ...

For the first time, researchers are leading a national study to see if the onset of nearsightedness can be delayed – and consequently reduced in magnitude over a lifetime – with the use of eyedrops in ...

A Prescription Drug User Fee Act target date of October 23, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ...

A study conducted at Vanderbilt University Medical Center and 11 other hospitals and practices across the United States shows that use of low-dose atropine eyedrops, commonly used in a higher dose to ...

We preselected all newsletters you had before unsubscribing.

Children with myopia using 0.05% atropine eye drops had less myopia progression and/or less axial elongation compared with those using placebo or 0.01% atropine, though they had higher rates of ...

Please provide your email address to receive an email when new articles are posted on . The study will examine 0.05% atropine drops for delaying onset of pediatric myopia in more than 600 children ...

In a cohort of over 1.2 million Taiwanese children followed up for at least 5 years, those with myopia had a higher risk for ocular problems than those without the condition. However, among children ...